Keyphrases
Clinical Markers
100%
Preeclampsia
100%
Biochemical Markers
100%
Individual Participant Data Meta-analysis
100%
Ultrasound Markers
100%
Clinical Characteristics
77%
Pregnancy Complications
44%
Pregnancy Prediction
44%
Characteristic Markers
44%
First Trimester
33%
Prediction Model
33%
Second Trimester
33%
Net Benefit
33%
Performance Prediction
22%
Prognostic Value
22%
C-statistic
22%
Singleton
22%
Clinical Utility
22%
Late-onset
11%
Confidence Interval
11%
Odds Ratio
11%
Validation Cohort
11%
Early Onset
11%
Maternal Mortality
11%
Singleton Pregnancy
11%
Tertiary Care
11%
High-risk Women
11%
Nulliparous Women
11%
Early Identification
11%
Perinatal Mortality
11%
Neonatal Morbidity
11%
History of Hypertension
11%
Random-effects Meta-analysis
11%
Between-study Variance
11%
International Survey
11%
Clinical Ultrasound
11%
Prediction of Preeclampsia
11%
Early-onset Preeclampsia
11%
Individual Participant Data
11%
UK NHS
11%
Population Characteristics
11%
Placental Growth Factor (PlGF)
11%
Decision Curve Analysis
11%
Prediction Interval
11%
Source Data
11%
Secondary Care
11%
Specific Performance
11%
Uterine Artery Pulsatility Index
11%
In-the-large
11%
Mode of Conception
11%
Characteristic Model
11%
Model Overfitting
11%
Population Heterogeneity
11%
Medicine and Dentistry
Meta-Analysis
100%
Pre-Eclampsia
100%
Complication of Pregnancy
36%
First Trimester Pregnancy
27%
Biochemical Marker
27%
Second Trimester Pregnancy
27%
Pregnancy
18%
Labor Onset
18%
Nulliparous
18%
Systematic Review
18%
Tertiary Care
9%
Maternal Mortality
9%
Cohort Analysis
9%
Perinatal Mortality
9%
Perinatal Morbidity
9%
Study Heterogeneity
9%
Conception
9%
Pulsatility Index
9%
Uterine Artery
9%
Population and Population Related Phenomena
9%
Placental Growth Factor
9%
Secondary Care
9%
Odds Ratio
9%
Biochemistry, Genetics and Molecular Biology
Eclampsia
100%
Second Trimester Pregnancy
27%
First Trimester Pregnancy
27%
Pregnancy
18%
Labor Onset
18%
Cohort Study
9%
Maternal Mortality
9%
Conception
9%
Placental Growth Factor
9%
Perinatal Morbidity
9%
Perinatal Mortality
9%
Population and Population Related Phenomena
9%
Pharmacology, Toxicology and Pharmaceutical Science
Preeclampsia
100%
Pregnancy Complication
36%
Biochemical Marker
27%
Cohort Study
9%
Population Study
9%
Perinatal Morbidity
9%
Perinatal Mortality
9%
Placental Growth Factor
9%
Maternal Mortality
9%